Posts

Eli Lilly and InnoCare sign China drug-discovery deal worth up to $3.35B

on

Caplyta may expand from bipolar depression into acute mania

on

Flagship Pioneering wins up to $47 million biodefense contract

on

Variant Bio Expands Boehringer Ingelheim Collaboration into Cardiovascular Disease

on

AI Tool Predicts Stable Molecular Forms to Speed Drug Discovery

on

Immunovant abandons cutaneous-lupus program after Phase 2 failure

on

Roche’s Phase 3 kidney-drug win sets up a fight with Novartis

on

FDA advisers question whether Grail’s Galleri test delivers meaningful early cancer detection

on

U.S. Officials Examine Germany’s Lower Drug Prices in Trade Hearing

on

Enveda raises $311M Series E to advance inflammation and weight-maintenance pipeline

on

Congress is tightening China biotech rules, but a total deal ban is unlikely

on

Celldex Falls Despite Positive Phase 3 Chronic-Hives Results

on

Ionis–Otsuka ALS Success and Boehringer’s Potential $1B Oncology Deal

on